Announcements Trials

Browse Landscape

Phase

Status

Completed 12 Recruiting 5 Active not recruiting 3 Unknown 2 Terminated 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 15 Recurrence 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Squamous Cell Carcinoma of Head and Neck 1 SCLC, Extensive Stage 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Medulloblastoma 1 Lung 1 Leukemia 1 Head and Neck Neoplasms 1 Extrapulmonary Neuroendocrine Cancer 1 Extensive Stage Lung Small Cell Cancer 1 Extensive Small Cell Lung Cancer 1 Ependymoma 1 ES-SCLC 1 Carcinoma, Squamous Cell 1 Carcinoma, Small Cell 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Merkel Cell 1 Carcinoma 1

Interventions

Temozolomide 2 fludarabine 1 Vascular Endothelial Growth Factor A 1 Triiodothyronine 1 Nivolumab 1 Irinotecan 1 Histocompatibility Testing 1 Etoposide 1 Cyclophosphamide 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Medulloblastoma × Etoposide × Clear all

NCT06485908 2024-07-03

MEPENDAX

Assistance Publique Hopitaux De Marseille

Phase 1/2 Not yet recruiting

Ependymoma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡